Eltrombopag for Enhancing Platelet Engraftment in Pediatric Patients Undergoing Cord Blood Transplantation

Trial Profile

Eltrombopag for Enhancing Platelet Engraftment in Pediatric Patients Undergoing Cord Blood Transplantation

Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 06 Jun 2017

At a glance

  • Drugs Eltrombopag (Primary)
  • Indications Thrombocytopenia
  • Focus Therapeutic Use
  • Most Recent Events

    • 15 Jun 2015 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrilas.gov.
    • 15 Jun 2015 Status changed from not yet recruiting to recruiting as reported by ClinicalTrilas.gov
    • 16 May 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top